Início › Câncer de Pulmão › Carolina do Norte › Durham
Ensaios clínicos de Câncer de Pulmão em Durham, NC
32 estudos para Câncer de Pulmão estão buscando participantes em locais em Durham e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecrutandoFase 3
- Duke University Medical Center, Durham
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RecrutandoFase 1/2
- Duke University, Durham
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Durham VA Medical Center, Durham
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RecrutandoFase 3
- Durham VA Medical Center, Durham
- Duke University Medical Center, Durham
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
RecrutandoFase 3
- Duke Cancer Center, Durham
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
RecrutandoFase 3
- UNC Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill · a 10 mi de distância
A Study of PHN-012 in Patients With Advanced Solid Tumors
RecrutandoFase 1
- PHN-012-001 Site, Durham
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
RecrutandoFase 3
- Duke University Medical Center, Durham
Study of Trilaciclib and Lurbinectidin
RecrutandoFase 2
- Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, Chapel Hill · a 10 mi de distância
Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
RecrutandoFase 2
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · a 10 mi de distância
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
RecrutandoFase 1/2
- Duke University School of Medicine, Durham
Effects of Infusion Timing on Treatment Response in Solid Tumors
RecrutandoFase 2
- University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill · a 10 mi de distância
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RecrutandoFase 3
- Duke Cancer Institute, Durham
- University of North Carolina Medical Center, Chapel Hill · a 10 mi de distância
The Vanguard Study: Testing a New Way to Screen for Cancer
RecrutandoVoluntários saudáveis bem-vindos
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · a 10 mi de distância
Health Education Approach to Lung Screening
RecrutandoVoluntários saudáveis bem-vindos
- University of North Carolina-Chapel Hill, Carrboro · a 11 mi de distância
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
RecrutandoFase 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · a 10 mi de distância
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
RecrutandoFase 1
- Xencor Investigative Site, Durham
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
RecrutandoFase 1/2
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · a 10 mi de distância
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
Recrutando
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill · a 10 mi de distância
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
RecrutandoFase 2
- University of North Carolina, Chapel Hill · a 10 mi de distância
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
RecrutandoFase 1
- Research Site, Durham
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RecrutandoFase 2
- Durham VA Medical Center, Durham
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RecrutandoFase 1
- Duke Cancer Center, Durham
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
RecrutandoFase 1/2
- University of North Carolina at Chapel Hill, Chapel Hill · a 10 mi de distância
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RecrutandoFase 2/3
- Durham VA Medical Center, Durham
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
RecrutandoVoluntários saudáveis bem-vindos
- Duke University, Durham
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Recrutando
- Durham VA Medical Center, Durham, NC, Durham
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RecrutandoFase 1
- Duke Cancer Institute, Durham
Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer
RecrutandoFase 1 inicial
- Lineberger Comprehensive Cancer Center, Chapel Hill · a 10 mi de distância
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecrutandoEstudo observacional
- Massive Bio SYNERGY-AI site, Chapel Hill · a 10 mi de distância
UNC Pleural Fluid Registry
RecrutandoEstudo observacional
- UNC Lingeberger Comprehensive Cancer Center, Chapel Hill · a 10 mi de distância
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
RecrutandoFase 2
- University of North Carolina, Chapel Hill · a 10 mi de distância
Ensaios de Câncer de Pulmão em outras cidades
- Houston, TX78 estudos
- Boston, MA62 estudos
- New York City, NY60 estudos
- Los Angeles, CA45 estudos
- Washington, DC41 estudos
- Arlington, VA41 estudos
- Chicago, IL41 estudos
- Nashville, TN40 estudos
- Baltimore, MD40 estudos
- St. Louis, MO39 estudos
- Columbus, OH37 estudos
- Philadelphia, PA36 estudos
Outros estudos em Durham
- Câncer de Mama63 estudos
- Câncer (todos os tipos)58 estudos
- Câncer de Pulmão de Não Pequenas Células39 estudos
- Mieloma Múltiplo37 estudos
- Câncer Metastático33 estudos
- Leucemia Mieloide Aguda33 estudos
- Câncer de Próstata32 estudos
- Câncer Colorretal28 estudos
- Leucemia Linfocítica Crônica27 estudos
- Câncer de Ovário27 estudos
- Insuficiência Cardíaca26 estudos
- Câncer de Pâncreas24 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.